Cancer News and Research

Latest Cancer News and Research

Scientists track down origins of fibrosis-promoting cells that scar and destroy organs

Scientists have tracked down and quantified the diverse origins of cells that drive fibrosis, the incurable, runaway wound-healing that scars and ultimately destroys organs such as the lungs, liver and kidneys.

2 Jul 2013

UNC scientists use GEMMs to develop biomarkers for molecular subtypes of human breast cancer

It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.

2 Jul 2013

ALK immunocytochemistry accurately detects NSCLC on cytological specimens

Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.

2 Jul 2013

Researchers use two new methods to detect levels of ALK protein expression in NSCLC

The implementation of personalized health care in cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.

2 Jul 2013

HDAC10 gene plays a key role in autophagy and resistance to chemotherapy in high-risk neuroblastomas

Neuroblastomas are pediatric tumors that originate from cells of the embryonic nervous system. The disease can take widely varying clinical courses that range from spontaneous regression to fatal outcomes.

2 Jul 2013

SBRT treatment safe and effective for stage I NSCLC, study finds

Stereotactic body radiotherapy is considered the treatment of choice for early-stage non-small-cell lung cancer if patients are inoperable because of additional medical conditions.

2 Jul 2013

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.

2 Jul 2013

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

Pathway Genomics Corporation, a San Diego-based clinical laboratory that offers genetic testing services internationally, has partnered with Parkway Laboratory Services Ltd, an ancillary service of Parkway Pantai Limited, the largest private healthcare provider in Singapore, and one of the largest private healthcare providers in Asia.

1 Jul 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

1 Jul 2013

Study: Watching avatar model weight-loss behavior in virtual community may help reduce weight

An estimated two-thirds of all Americans are overweight or obese and many find it difficult to lose weight and keep it off. They've tried fad diets, exercise programs, diet pills and other methods but the battle continues. Now, a new study suggests that watching an avatar model weight-loss behavior in a virtual community might help some women shed pounds in the real world.

1 Jul 2013

Arizona State University physicist explains new theory of cancer

With death rates from cancer have remained largely unchanged over the past 60 years, a physicist is trying to shed more light on the disease with a very different theory of its origin that traces cancer back to the dawn of multicellularity more than a billion years ago.

1 Jul 2013

Nano and laser technology packed into small device tests antibiotic treatment in minutes

Researchers at EPFL have built a matchbox-sized device that can test for the presence of bacteria in a couple of minutes, instead of up to several weeks. A nano-lever vibrates in the presence of bacterial activity, while a laser reads the vibration and translates it into an electrical signal that can be easily read-the absence of a signal signifies the absence of bacteria.

1 Jul 2013

Researchers discover an important mechanism that regulates proteasome activity

Dysfunction of the ubiquitin-proteasome system (UPS) has been detected in many neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and certain types of cancer. Such dysfunction is also believed to be related to some degenerative muscle diseases. Researchers at the University of Helsinki, Finland, have now discovered an important mechanism that regulates proteasome activity.

1 Jul 2013

Tiny RNA molecules work as powerful regulators of immune response in mammals

A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.

1 Jul 2013

Study shows autophagy blockers play a role in treatment of non-small-cell lung cancer

New research from Rutgers Cancer Institute of New Jersey, Princeton University and other collaborators suggests that inactivation of an essential gene responsible for the cell survival process known as autophagy can suppress the growth of non-small-cell lung cancer tumors and render them more benign.

1 Jul 2013

Study: Tobacco control measures to prevent some 7.4 million premature deaths by 2050

Tobacco control measures put in place in 41 countries between 2007 and 2010 will prevent some 7.4 million premature deaths by 2050, according to a study published in the Bulletin of the World Health Organization today.

1 Jul 2013

Biomarker indicates which women are at risk for breast cancer recurrence after tamoxifen

A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.

30 Jun 2013

Study shows lymphatic circulatory system may be intimately involved in vascular disorders

The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.

30 Jun 2013

Physical activity and low calorie food may reduce risk of aggressive prostate cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have published the first study on adherence to eight World Cancer Research Fund (WCRF) lifestyle recommendations and aggressive prostate cancer that shows a significantly decreased risk of highly aggressive prostate cancer associated with closer adherence to the recommendations.

30 Jun 2013

Molecular protein folding process may help medical researchers understand and treat diseases

Scientists using sophisticated imaging techniques have observed a molecular protein folding process that may help medical researchers understand and treat diseases such as Alzheimer's, Lou Gehrig's and cancer.

30 Jun 2013

Cancer News and Research

Latest Cancer News and Research

Scientists track down origins of fibrosis-promoting cells that scar and destroy organs

UNC scientists use GEMMs to develop biomarkers for molecular subtypes of human breast cancer

ALK immunocytochemistry accurately detects NSCLC on cytological specimens

Researchers use two new methods to detect levels of ALK protein expression in NSCLC

HDAC10 gene plays a key role in autophagy and resistance to chemotherapy in high-risk neuroblastomas

SBRT treatment safe and effective for stage I NSCLC, study finds

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Study: Watching avatar model weight-loss behavior in virtual community may help reduce weight

Arizona State University physicist explains new theory of cancer

Nano and laser technology packed into small device tests antibiotic treatment in minutes

Researchers discover an important mechanism that regulates proteasome activity

Tiny RNA molecules work as powerful regulators of immune response in mammals

Study shows autophagy blockers play a role in treatment of non-small-cell lung cancer

Study: Tobacco control measures to prevent some 7.4 million premature deaths by 2050

Biomarker indicates which women are at risk for breast cancer recurrence after tamoxifen

Study shows lymphatic circulatory system may be intimately involved in vascular disorders

Physical activity and low calorie food may reduce risk of aggressive prostate cancer

Molecular protein folding process may help medical researchers understand and treat diseases

Industry Focus eBook - Oncology (3rd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (3rd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in